Patent intelligence · CA
CA 2785117
SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES
SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES
Patent details — CA 2785117
- Jurisdiction
- CA
- Status
- granted
- Grant date
- Jun 30, 2011
- Expiration
- Jun 25, 2031
- Applicant
- ACINO AG [DE]
- CPC classes
- A61K 9/ 70 A I, A61K 31/ 27 A I, A61K 31/ 55 A I, A61K 31/ 445 A I
Quick answer
CA 2785117 (SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES) is held by ACINO AG [DE]. Status: granted. Granted Jun 30, 2011. Expires Jun 25, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ACINO AG [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 70 A I, A61K 31/ 27 A I, A61K 31/ 55 A I, A61K 31/ 445 A I, A61K 31/ 4468 A I, A61K/3127
More from ACINO AG [DE]
Related pharmaceutical patents in our USPTO index.
-
CH 711279
Verpacktes Arzneimittel, umfassend eine Retardformulierung von Naloxon oder einem pharmazeutisch verträglichen Salz davon, und eine Verpackung.
granted -
DE 202016005375
Verminderung der Deallylierung von Naloxon während der Lagerung einer naloxonhaltigen Retardformulierung
granted -
EP 3067050
TRANSDERMALES THERAPEUTISCHES SYSTEM MIT EINEM OVERTAPE MIT ZWEI HAFTSCHICHTEN
granted -
WO 2016001312
DISPOSITIF POUR LA FABRICATION DE TIMBRES PHARMACEUTIQUES
granted -
WO 2015165821
VERFAHREN UND VORRICHTUNG ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG
granted -
US 2015112285
Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
granted -
EP 2804734
GITTERVERLUSTREDUKTION BEI PFLASTERHERSTELLUNG
granted -
EP 2682113
Verschließen wirkstoffhaltiger Laminate
granted
Frequently asked questions
What is US patent 2785117?
CA 2785117 (SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES) is held by ACINO AG [DE]. Status: granted. Granted Jun 30, 2011. Expires Jun 25, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2785117?
ACINO AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2785117 expire?
Our index shows an expiration date of Jun 25, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.